25 February 2022

A group from the Bellvitge University Hospital and IDIBELL has shown that a genetic variant of the bacterium would be associated with higher production of biofilm, a self-protection system that allows it to persist in the environment

17 February 2022

A study just published in the journal Nature Medicine, led by the University Hospital of Bellvitge and IDIBELL, and other international centers, has discovered that two antibodies naturally present in humans are responsible for triggering the immune response that causes the deterioration of heart implants of animal origin.

11 February 2022

The improvement of the epidemiological situation during the last few days has allowed receiving one visitor for patients in hospitalisation, critical and semi-critical units in non-Covid areas

10 February 2022

The study, published in the Lancet Respiratory Medicine, shows no differences in complications that require hospitalization between people with COVID-19 who received intravenous plasma infusion and those who did not.

09 February 2022

A study by CIBERDEM, Bellvitge University Hospital, IDIBELL, and IIB-Sant Pau shows that miR-125b affects the ability of HDL lipoproteins to extract cholesterol from macrophages and smooth muscle cells of the arterial wall, accelerating the development of atherosclerotic plaque

The study opens the way to a possible use of inhibitors of this miRNA as a therapeutic strategy to stop the progression of this vascular condition

08 February 2022

This new surgical technique, developed in the United States, reduces surgery time and the risk of complications